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likely because they increased access to poor-quality care. What
can India do to demonstrate its
commitment to quality? Investments in collecting data in electronic records that systematically
measure quality are part of the
solution, but we believe that a
national program that defines
and tracks quality across the
spectrum of care is crucial. Beyond the health benefits of improving quality, such programs
build trust, encouraging people
to return. Without deliberate attention to and action on quality,
it’s unlikely that the reform will
lead to better health outcomes.
The Indian health insurance
scheme will be studied closely.
Five Indian states are opting out
of the reform; the reach and success of Ayushman Bharat will be
determined in part by the ability
of these states to effectively demonstrate that their models are expanding access, providing financial protection, and improving
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health outcomes. Parts of India
have health indicators comparable to those of southern Europe,
while other areas mirror parts of
sub-Saharan Africa. No single
strategy will work, but India’s diverse landscape also means that
an extraordinary learning opportunity for implementing universal health coverage on a vast scale
is unfolding. If the government
invests heavily in evaluations, testing new approaches, and listening
intently to states, it can ensure
that relevant lessons are learned.
India’s bold step toward reform
reflects an increasingly interconnected world and the desire of all
people to have access to the
fruits of modern medicine. From
Mexico in 2006, to the United
States in 2010, to China in 2016,
to India now, universal coverage
has become reform’s rallying cry.
A high-profile failure, however,
will set this movement back. India
has the formula to succeed, and
we believe the emphases outlined

here can help India show the
world that health care for all is
eminently possible, even in the
most complex of circumstances.
Disclosure forms provided by the authors
are available at NEJM.org.
From the Harvard Global Health Institute,
Harvard T.H. Chan School of Public Health,
Boston.
This article was published on May 22, 2019,
at NEJM.org.
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The Hospital Readmissions Reduction Program
— Time for a Reboot
Rishi K. Wadhera, M.D., M.P.P., Robert W. Yeh, M.D., and Karen E. Joynt Maddox, M.D., M.P.H.

T

he Hospital Readmissions Reduction Program (HRRP) was
established by the Centers for
Medicare and Medicaid Services
(CMS) in 2010 with a goal of
reducing preventable hospitalizations by imposing financial penalties on hospitals with higherthan-expected 30-day readmission
rates. After the program was created, readmission rates appeared
to decrease nationwide for patients
hospitalized with heart failure,
acute myocardial infarction, and
pneumonia, the three conditions
it originally targeted.

Some policymakers have pushed
for the HRRP to be expanded to
cover all conditions treated in
inpatient settings. Others, including many clinicians and researchers, have expressed skepticism
regarding the program’s effects
and concerns about unintended
consequences. These concerns
stem from three major limitations
of the program.
First, the HRRP defines only
inpatient hospitalizations — not
observation stays or emergency
department (ED) visits — as readmissions, which has artificially
n engl j med 380;24 nejm.org
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inflated estimates of its success.
Although readmission rates have
decreased for targeted conditions,
rates of observation stays and ED
visits after inpatient stays have
increased; as a result, the proportion of patients who return to
a hospital within 30 days after
discharge has not changed. This
blind spot also creates strong incentives to treat patients in EDs
or observation units to avoid readmissions, even if inpatient hospitalization would improve their
access to appropriate care. The
HRRP also doesn’t include ob2289
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servation stays as index events,
so little is known about postdischarge outcomes for patients admitted under observation status.
Since hospitals vary widely in
their use of observation units,
excluding these stays may create
an uneven playing field for comparing hospital performance.
A second limitation is that the
HRRP metric doesn’t account for
the competing risk of death. A patient who dies can no longer be
readmitted. But because deaths
aren’t factored into readmission
rates, hospitals that keep more
patients alive and therefore discharge a sicker group of people
may be penalized for having higher readmission rates rather than
rewarded for having good outcomes. This problem is exacerbated by the fact that penalties
for high readmission rates under
the HRRP are much larger than
penalties for high mortality under the Hospital Value-Based Purchasing program.
Third, risk adjustment of the
readmission measure is inadequate, which encumbers fair comparisons among hospitals. Readmission models are notoriously
poor at predicting events. Although
coexisting conditions such as diabetes are well captured in riskadjustment models, factors such
as functional status and frailty,
which meaningfully improve risk
prediction, are not. Health care
utilization patterns are also not
accounted for in current models.
As a result, differences in severity
of illness between a person with
heart failure who has one brief
hospitalization for swollen ankles
and another who is repeatedly
hospitalized for decompensated
heart failure are poorly captured.
Because of their relative simplicity, current models are also easy
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to “game.” Growing evidence suggests that much of the reported
improvement in risk-adjusted readmission rates that drove early
enthusiasm for the program may
have been the result of an artificial increase in coded coexisting
conditions rather than improvements in care quality.
Current risk-adjustment models also omit social risk factors
that are strongly related to re
admissions, such as poverty, so
hospitals tend to be penalized
for serving poor and vulnerable
patients. Safety-net hospitals are
frequently penalized under the
HRRP, which results in a transfer
of resources away from resourcepoor sites. The 21st Century
Cures Act implemented a stratification scheme in the HRRP this
year such that hospitals are compared only with other facilities
that treat Medicare populations
with similar poverty levels. This
change was associated with a significant reduction in penalties for
safety-net hospitals.
Finally, mounting evidence suggests that the HRRP may have
had unintended consequences,
particularly for patients with heart
failure. Four independent studies
revealed that mortality within 30
days after discharge from a hospitalization for heart failure increased significantly after implementation of the HRRP relative
to earlier trends.1-4 This increase
was concentrated among patients
who weren’t readmitted, which
raises the possibility that greater
use of EDs and observation units
by hospitals to reduce readmissions may adversely affect patients
who would benefit from higherlevel care.
Two studies have come to different conclusions, however. One
investigation, by the group that
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developed the readmission measure, found that although 30-day
postdischarge mortality among
patients with heart failure increased after the HRRP was enacted, changes from previous
trends were not statistically significant.5 A report by the Medicare
Payment Advisory Commission
showed that raw in-hospitalthrough-postdischarge mortality
among patients with heart failure increased between 2008 and
2016, but risk-adjusted mortality
decreased — from 13.6% to 9.4%.
In contrast, studies have consistently found that mortality among
patients hospitalized for myocardial infarction has not increased
under the HRRP,1,5 which suggests that acute conditions may
be better suited to the program
than chronic conditions such as
heart failure.
How can we strengthen the
HRRP to mitigate potential unintended consequences and ensure
that the program improves care
quality and patient outcomes?
Rather than using only inpatient readmission rates to evaluate hospital performance, the
HRRP could use a “return-tohospital” metric that also includes rates of ED visits and observation-unit stays within 30 days
after discharge. These outcomes
wouldn’t have to be weighted
equally. Such a measure would
strengthen hospitals’ incentive to
focus on improving care transitions and postdischarge care to
reduce unnecessary returns to the
hospital. It would also encourage
hospitals to make more considered care decisions for patients
who do return and permit a fairer
assessment of hospitals’ performance. Furthermore, treating both
inpatient and observation-unit
stays as index events could pro-
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vide a more comprehensive picture of hospital-based encounters
after discharge.
In addition, we believe the
metric used in the HRRP should
account for the competing risk
of death, both during and after
hospitalization. One potential approach would be to evaluate performance during the period patients are alive within 30 days
after discharge. Another possibility would be to create a joint outcome measure that combines hospital returns and deaths within
30 days. CMS could also ensure
that financial incentives to reduce
mortality are greater than incentives to reduce readmissions.
The HRRP’s risk-adjustment
methods could also be improved.
The evidence that social risk factors influence readmission rates is
incontrovertible. Directly adjusting for dual-enrollment status
(coverage under both Medicare
and Medicaid) in risk models
would allow all hospitals to receive similar “credit” for caring
for vulnerable patients. Although
dual status is a somewhat limited measure of social risk, a growing body of evidence suggests
that adding more detailed socialrisk data adds little to risk prediction. On the other hand, adding
covariates such as prior hospital
utilization, functional status, and
frailty meaningfully improves risk
models, particularly for poor and
disabled populations. By focusing on more holistic risk adjust-
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ment, such changes might also
make the metric less gameable.
In the long run, CMS could
consider using revenue generated from the HRRP to assist
resource-poor hospitals that consistently have high readmission
rates in improving discharge planning or care coordination services. Since many factors that
drive readmissions act outside
hospital walls, assistance might
be most valuable if used to improve postdischarge primary and
specialty care, address social determinants of health, and create
linkages between hospitals and
community partners. Pairing penalties with resources to encourage implementation of innovative
programs focused on resourcepoor settings could help ensure
that the HRRP’s net effect is positive.
More broadly, the ongoing debate about the HRRP underscores
the consequences of implementing national policies with no control group and no plan for iterative improvement. For this reason,
we believe any change to the
HRRP should be made in the
context of a robust evaluation
effort to determine its effect on
patient experience, care quality,
and outcomes. Throughout the
process, we believe it is imperative that policymakers seek input
from frontline clinicians and patients who understand the realworld effects of this program.
Together, these improvements
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could reboot the HRRP and transform it from a regressive penalty
program to a progressive program that improves patient care.
Disclosure forms provided by the authors
are available at NEJM.org.
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This article was published on May 15, 2019,
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